Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer

INTRODUCTION: We performed a retrospective analysis of HER2-overexpressing metastatic breast cancer patients to describe clinical outcomes of those who, despite progression of the disease (PD), maintained trastuzumab for multiple chemotherapy lines. We also compared survival of these patients with t...

Full description

Saved in:
Bibliographic Details
Main Authors: Cancello, Giuseppe, Montagna, Emilia, D'Agostino, Diego, Giuliano, Mario, Giordano, Antonio, Di Lorenzo, Giuseppe, Plaitano, Monica, De Placido, Sabino, De Laurentiis, Michele
Format: Artigo
Language:Inglês
Published: BioMed Central 2008
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2575533/
https://ncbi.nlm.nih.gov/pubmed/18631394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2119
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items